Skip to main content
. 2015 Apr 7;21(13):3876–3887. doi: 10.3748/wjg.v21.i13.3876

Figure 1.

Figure 1

Cancer stem cells are enriched in established gemcitabine-resistant cells. A: Panc1-RG cells were established by long-term step-wise gemcitabine treatment. WST assay showed that Panc1-RG cells exhibited gemcitabine resistance compared with Panc1-P cells; B: Flow cytometric analysis showing a higher ratio of CD24+/CD44+ cells in Panc1-RG cells compared with Panc1-P cells. All results are expressed as mean ± SD; aP < 0.05 vs Panc1-P cells.